Fresenius Medical Care AG (FMS)
22.16
+0.18
(+0.82%)
USD |
NYSE |
Nov 22, 16:00
22.17
+0.01
(+0.05%)
After-Hours: 20:00
Fresenius Medical Care Revenue (Quarterly): 5.235B for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 5.235B |
| June 30, 2024 | 5.132B |
| March 31, 2024 | 5.132B |
| December 31, 2023 | 5.371B |
| September 30, 2023 | 5.374B |
| June 30, 2023 | 5.261B |
| March 31, 2023 | 5.052B |
| December 31, 2022 | 5.109B |
| September 30, 2022 | 5.134B |
| June 30, 2022 | 5.067B |
| March 31, 2022 | 5.104B |
| December 31, 2021 | 5.315B |
| September 30, 2021 | 5.237B |
| June 30, 2021 | 5.207B |
| March 31, 2021 | 5.073B |
| December 31, 2020 | 5.246B |
| September 30, 2020 | 5.161B |
| June 30, 2020 | 5.019B |
| March 31, 2020 | 4.952B |
| December 31, 2019 | 5.072B |
| September 30, 2019 | 4.914B |
| June 30, 2019 | 4.881B |
| March 31, 2019 | 4.694B |
| December 31, 2018 | 4.906B |
| September 30, 2018 | 4.718B |
| Date | Value |
|---|---|
| June 30, 2018 | 5.031B |
| March 31, 2018 | 4.884B |
| December 31, 2017 | 5.215B |
| September 30, 2017 | 5.097B |
| June 30, 2017 | 4.919B |
| March 31, 2017 | 4.845B |
| December 31, 2016 | 4.765B |
| September 30, 2016 | 4.701B |
| June 30, 2016 | 4.548B |
| March 31, 2016 | 4.320B |
| December 31, 2015 | 4.862B |
| September 30, 2015 | 4.179B |
| June 30, 2015 | 4.137B |
| March 31, 2015 | 4.126B |
| December 31, 2014 | 4.930B |
| September 30, 2014 | 4.295B |
| June 30, 2014 | 3.855B |
| March 31, 2014 | 3.550B |
| December 31, 2013 | 3.565B |
| September 30, 2013 | 3.601B |
| June 30, 2013 | 3.627B |
| March 31, 2013 | 3.571B |
| December 31, 2012 | 3.338B |
| September 30, 2012 | 3.328B |
| June 30, 2012 | 3.477B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
4.952B
Minimum
Mar 2020
5.374B
Maximum
Sep 2023
5.163B
Average
5.133B
Median
Revenue (Quarterly) Benchmarks
| BioNTech SE | 1.369B |
| Affimed NV | 0.1705M |
| InflaRx NV | 0.1362M |
| Immatics NV | 55.61M |
| CureVac NV | 543.20M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 234.26M |
| Total Expenses (Quarterly) | 4.771B |
| EPS Diluted (Quarterly) | 0.4014 |
| Enterprise Value | 11.47B |
| Gross Profit Margin (Quarterly) | 24.08% |
| Profit Margin (Quarterly) | 4.47% |
| Earnings Yield | 5.51% |
| Operating Earnings Yield | 15.07% |
| Normalized Earnings Yield | 6.414 |